Clinical Trial Update: Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating intrathecal administration of hematopoietic stem cells in amyotrophic lateral sclerosis has completed both Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Intrathecal hematopoietic stem cell therapy (hematopoietic stem cells)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: COMPLETED